| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC20921 | CDK5 inhibitor 20-223 | CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9. |
|
| DC12528 | CDK9 inhibitor HH1 Featured | CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.. |
|
| DC20335 | CDK9-IN-8 Featured | CDK9-IN-8 is a highly potent, selective CDK9 inhibitor with IC50 of 12 nM, shows good selectivity in CDKs kinase profiling assay against CDK kinases and cell proliferation inhibition. |
|
| DC9478 | CDK9-IN-1 | CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection. |
|
| DC23138 | CDK-I73 Featured | CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM. |
|
| DC9390 | CDK-IN-2 Featured | CDK-IN-2 is a potent and sepecific CDK inhibitor. |
|
| DC11393 | CDM-NAG Featured | CDM-NAG is a useful tool compound to deliver the siRNA. |
|
| DC10948 | CDN1163 Featured | CDN1163 (CDN-1163) is a small molecule, allosteric activator of SERCA2, dose-dependently increases the Vmax of SERCA2 Ca2+-ATPase activity in ER microsomes; increases Ca2+-ATPase activity and significantly enhances Ca2+ uptake into the ER, attenuates H2O2-stimulated cell death in HEK cells; improves glucose homeostasis and metabolic parameters, increases glucose tolerance in ob/ob mice; CDN1163 reduces lipid accumulation and decreases lipogenesis in obese mice livers. |
|
| DC20879 | CDP-840 | CDP-840 (CDP840. |
|
| DC20880 | CDP-840 hydrochloride | CDP-840 (CDP840. |
|
| DC23463 | CDPPB Featured | CDPPB is a potent, selective, brain penetrant positive allosteric modulator of mGlu5 receptor with EC50 of 10 nM and 20 nM for human and rat mGluR5, respectively. |
|
| DC22446 | CE-224535 | CE-224535 (PF-04905428) is a potent and selective P2X7 receptor antagonist with IC50 of 1.4 nM (inhibition of the release of lL-1b from monocytes stimulated by ATP). |
|
| DC20881 | CE-245677 | CE-245677 is a potent, selective, orally active, dual Tie2/Trk kinase inhibitor with IC50 of 4.7 nM, 1 nM for Tie2 and TrkA/B, respectively. |
|
| DC20336 | CE3F4 Featured | CE3F4 is a potent, noncompetitive EPAC1 inhibitor that blocks EPAC1-induced Rap1 activation both in cell-free systems and in intact cells and did not influence protein kinase A holoenzyme activity. |
|
| DC23912 | Cecropin B | Cecropin B is an antimicrobial peptide with MICs(0.5 to 16 ug/ml) against Gramnegative strains. |
|
| DC20987 | Cedazuridine Featured | Cedazuridine (E7727) is a novel cytidine deaminase inhibitor, and a componet of ASTX727 for treatment of hematologic malignancies.. |
|
| DC3170 | Cediranib Featured | Cediranib (AZD2171) is a highly potent VEGFR2 inhibitor with IC50 of 0.5 nM, also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM. |
|
| DCAPI1386 | Cefdinir (Omnicef) | Cefdinir (Omnicef) |
|
| DCAPI1024 | Cefditoren pivoxil | Cefditoren pivoxil |
|
| DC8686 | Cefetamet pivoxil hydrochloride | Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic. |
|
| DC9358 | Cefmenoxime (hydrochloride) | Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic. |
|
| DCAPI1038 | Cefoselis sulfate | Cefoselis sulfate |
|
| DC20190 | Cefoxitin | Cefoxitin is a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. |
|
| DC8067 | Cefozopran Featured | Cefozopran (SCE-2787) is a new parenteral cephalosporin, against experimental infections in mice. |
|
| DC9356 | Cefpiramide (sodium) | Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. |
|
| DC8687 | Cefpirome sulfate | Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. |
|
| DCAPI1033 | Cefprozil hydrate (Cefzil) | Cefprozil hydrate (Cefzil) |
|
| DC9355 | Ceftibuten (dihydrate) | Ceftibuten dihydrate is a third-generation cephalosporin antibiotic. |
|
| DC12245 | Ceftizoxime | Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan. |
|
| DCAPI1155 | Celastrol Featured | Celastrol is a potent proteasome inhibitor for the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. |
|
